NCT07770191

Brief Summary

Blood draw is a common invasive procedure that can cause pain and fear in children. This randomized controlled trial aims to compare the effects of pinwheel blowing, 3D hologram viewing, and sugar-free gum chewing on pain and fear during blood draw among children aged 5-10 years. Parental satisfaction with the care provided during the procedure will also be evaluated. A total of 164 children will be assigned in a 1:1:1:1 ratio to the pinwheel blowing, 3D hologram viewing, gum chewing, or control group using block randomization stratified by age and sex. The interventions will begin one minute before the blood draw and continue until the procedure is completed. Children in the control group will receive the routine blood draw procedure without any additional nonpharmacological intervention. Immediately after the blood draw, the child's pain and fear during the procedure will be independently evaluated by the child, the accompanying parent, and an independent observer nurse. Parental satisfaction will also be assessed after the procedure.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 15, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 18, 2026

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 15, 2026

Completed
Last Updated

August 18, 2026

Status Verified

August 1, 2026

Enrollment Period

3 months

First QC Date

August 8, 2026

Last Update Submit

August 14, 2026

Conditions

Keywords

Distraction3D HologramGum Chewing

Outcome Measures

Primary Outcomes (2)

  • Child-Reported Pain Intensity During Blood Draw Assessed Using the Wong-Baker FACES Pain Rating Scale

    Pain experienced during the blood draw will be assessed by the child using the Wong-Baker FACES Pain Rating Scale. The scale consists of six faces scored as 0, 2, 4, 6, 8, and 10, where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain intensity.

    Immediately after the blood draw, within approximately 5 minutes

  • Child-Reported Fear During Blood Draw Assessed Using the Children's Fear Scale

    Fear experienced during the blood draw will be assessed by the child using the Children's Fear Scale. The scale consists of five facial expressions scored from 0 to 4, where 0 indicates no fear and 4 indicates extreme fear. Higher scores indicate greater fear.

    Immediately after the blood draw, within approximately 5 minutes

Secondary Outcomes (1)

  • Parent-Reported Satisfaction With the Blood Draw Procedure

    Immediately after the blood draw, within approximately 5 minutes

Study Arms (4)

3D Hologram Viewing Group

EXPERIMENTAL

Children will watch an age-appropriate 3D holographic video featuring colorful flying butterflies. The intervention will begin one minute before the blood draw and continue until the procedure is completed.

Behavioral: 3D Hologram Viewing

Pinwheel Blowing Group

EXPERIMENTAL

Children will begin blowing a colorful handheld pinwheel one minute before the blood draw and continue until the procedure is completed.

Behavioral: Pinwheel Blowing

Gum Chewing Group

EXPERIMENTAL

Children will select a flavored sugar-free gum, begin chewing it one minute before the blood draw, and continue until the procedure is completed.

Behavioral: Gum Chewing

Control Group

NO INTERVENTION

Children will receive the routine blood draw procedure used in the pediatric phlebotomy unit. No additional pharmacological or nonpharmacological pain-relieving intervention will be provided. The accompanying parent will remain with the child and may talk to and maintain eye contact with the child during the procedure.

Interventions

Children will watch an age-appropriate 3D holographic video featuring colorful flying butterflies. The holographic display will be positioned approximately 50 cm from the child. The intervention will begin one minute before the blood draw and continue until the procedure is completed.

3D Hologram Viewing Group

Children blow a colorful handheld pinwheel with a diameter of 16 cm. The intervention begins one minute before the blood draw and continues until the procedure is completed. Children hold the pinwheel with the hand not used for blood collection; the researcher holds it when necessary.

Pinwheel Blowing Group
Gum ChewingBEHAVIORAL

Children will select a 14.5-g piece of sugar-free flavored gum and begin chewing it one minute before the blood draw. The available flavors will include watermelon, strawberry, orange, and mixed fruit. Children will continue chewing the gum until the procedure is completed.

Gum Chewing Group

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 5 to 10 years
  • Scheduled to undergo a blood draw
  • No analgesic medication use within 6 hours before the procedure
  • No visual, hearing, or speech impairment
  • No neurological disorder
  • No oral or jaw condition that may prevent gum chewing
  • No chronic illness requiring frequent invasive procedures
  • Written informed consent provided by the parent or legal guardian
  • Verbal assent provided by the children

You may not qualify if:

  • Previous history of syncope during blood draw procedures
  • Blood draw not completed on the first attempt
  • Development of syncope during the procedure
  • Inability or unwillingness to complete the assigned intervention
  • Withdrawal of consent or assent by the parent or child at any stage of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tekirdağ City Hospital

Tekirdağ, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Agnosia

Interventions

Chewing Gum

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Plant GumsBiopolymersPolymersMacromolecular SubstancesPolysaccharidesCarbohydratesPlant ExudatesBiological ProductsComplex MixturesCandyFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Officials

  • Gülsev Kutman

    Tekirdağ City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gülsev Kutman, Rn Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Blinding was not possible because the interventions were directly visible to the participants, parents, researcher, phlebotomy nurse, and observer nurse.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants are assigned to one of four parallel study groups: 3D hologram viewing, pinwheel blowing, gum chewing, or control.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator and Pediatric Nurse

Study Record Dates

First Submitted

August 8, 2026

First Posted

August 18, 2026

Study Start

June 15, 2026

Primary Completion

September 15, 2026

Study Completion

September 15, 2026

Last Updated

August 18, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared because the informed consent process and ethics committee approval did not include the sharing of participant-level data with other researchers. As the study involves children, participant privacy and confidentiality will be strictly protected. Only aggregate study findings will be reported in scientific publications.

Locations